21 related articles for article (PubMed ID: 21486696)
1. Successes in antiviral drug discovery: a tribute to Nick Meanwell.
Rotella DP
Med Chem Res; 2023 Jun; ():1-10. PubMed ID: 37362321
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective palladium(0)-catalyzed intramolecular cyclopropane functionalization: access to dihydroquinolones, dihydroisoquinolones and the BMS-791325 ring system.
Pedroni J; Saget T; Donets PA; Cramer N
Chem Sci; 2015 Sep; 6(9):5164-5171. PubMed ID: 29142735
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibition for BMS-791325, a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase.
Rigat KL; Lu H; Wang YK; Argyrou A; Fanslau C; Beno B; Wang Y; Marcinkeviciene J; Ding M; Gentles RG; Gao M; Abell LM; Roberts SB
J Biol Chem; 2014 Nov; 289(48):33456-68. PubMed ID: 25301950
[TBL] [Abstract][Full Text] [Related]
4. Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing.
Margeridon-Thermet S; Le Pogam S; Li L; Liu TF; Shulman N; Shafer RW; Najera I
PLoS One; 2014; 9(8):e105569. PubMed ID: 25140696
[TBL] [Abstract][Full Text] [Related]
5. Effect on hepatitis C virus replication of combinations of direct-acting antivirals, including NS5A inhibitor daclatasvir.
Pelosi LA; Voss S; Liu M; Gao M; Lemm JA
Antimicrob Agents Chemother; 2012 Oct; 56(10):5230-9. PubMed ID: 22850513
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymerase.
Ding M; He F; Hudyma TW; Zheng X; Poss MA; Kadow JF; Beno BR; Rigat KL; Wang YK; Fridell RA; Lemm JA; Qiu D; Liu M; Voss S; Pelosi LA; Roberts SB; Gao M; Knipe J; Gentles RG
Bioorg Med Chem Lett; 2012 Apr; 22(8):2866-71. PubMed ID: 22424979
[TBL] [Abstract][Full Text] [Related]
7. I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles.
Anilkumar GN; Lesburg CA; Selyutin O; Rosenblum SB; Zeng Q; Jiang Y; Chan TY; Pu H; Vaccaro H; Wang L; Bennett F; Chen KX; Duca J; Gavalas S; Huang Y; Pinto P; Sannigrahi M; Velazquez F; Venkatraman S; Vibulbhan B; Agrawal S; Butkiewicz N; Feld B; Ferrari E; He Z; Jiang CK; Palermo RE; McMonagle P; Huang HC; Shih NY; Njoroge G; Kozlowski JA
Bioorg Med Chem Lett; 2011 Sep; 21(18):5336-41. PubMed ID: 21840715
[TBL] [Abstract][Full Text] [Related]
8. The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
Jackson RW; LaPorte MG; Herbertz T; Draper TL; Gaboury JA; Rippin SR; Patel R; Chunduru SK; Benetatos CA; Young DC; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2011 Jun; 21(11):3227-31. PubMed ID: 21550237
[TBL] [Abstract][Full Text] [Related]
9. Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors.
Ikegashira K; Oka T; Hirashima S; Noji S; Yamanaka H; Hara Y; Adachi T; Tsuruha J; Doi S; Hase Y; Noguchi T; Ando I; Ogura N; Ikeda S; Hashimoto H
J Med Chem; 2006 Nov; 49(24):6950-3. PubMed ID: 17125247
[TBL] [Abstract][Full Text] [Related]
10. Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase.
Stansfield I; Ercolani C; Mackay A; Conte I; Pompei M; Koch U; Gennari N; Giuliano C; Rowley M; Narjes F
Bioorg Med Chem Lett; 2009 Feb; 19(3):627-32. PubMed ID: 19131244
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus.
Zheng X; Hudyma TW; Martin SW; Bergstrom C; Ding M; He F; Romine J; Poss MA; Kadow JF; Chang CH; Wan J; Witmer MR; Morin P; Camac DM; Sheriff S; Beno BR; Rigat KL; Wang YK; Fridell R; Lemm J; Qiu D; Liu M; Voss S; Pelosi L; Roberts SB; Gao M; Knipe J; Gentles RG
Bioorg Med Chem Lett; 2011 May; 21(10):2925-9. PubMed ID: 21486696
[TBL] [Abstract][Full Text] [Related]
12. 2-hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid with inbuilt β-N-hydroxy-γ-keto-acid pharmacophore as HCV NS5B polymerase inhibitors.
Deore RR; Chen GS; Chen CS; Chang PT; Chuang MH; Chern TR; Wang HC; Chern JW
Curr Med Chem; 2012; 19(4):613-24. PubMed ID: 22204334
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]